Press release
Europe SGLT2 Inhibitors Market Opportunity, Challenge, Trend, Global Business Growth Forecast By 2023-2032 | AstraZeneca, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company
Europe SGLT2 Inhibitors Market
๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐จ๐ฉ๐:
This comprehensive study provides an accurate overview of the worldwide Europe SGLT2 inhibitors market. Comprehensive analyses of sales volume, price, revenue, market share, and important companies are included. The market is further divided into segments by indication, drug, distribution channel, and country in the study, which offers a comprehensive picture of the state of the market.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ ๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/europe-sglt2-inhibitors-market/request-for-sample
๐๐๐ซ๐ค๐๐ญ ๐๐๐๐ข๐ง๐ข๐ญ๐ข๐จ๐ง:
SGLT2 inhibitors are drugs that help manage type 2 diabetes by stopping the SGLT2 protein in the kidneys from reabsorbing glucose, leading to its removal through urine. Assisting in decreasing glucose levels in the body, it can also aid in weight loss and lowering blood pressure. They offer extra advantages for the heart and kidneys, proving useful in treating complications related to diabetes.
Drivers and Trends:
โข With the aging population in Europe on the rise, there is a higher occurrence of chronic conditions like heart disease, diabetes, and cancer. It has led to an increasing need for SGLT2 inhibitors to manage chronic conditions, such as hypertension and type 2 diabetes.
โข European administrations are putting in place a range of strategies like offering financial aid for diabetes drugs, enhancing healthcare availability, and focusing on preventative health services. These policies aim to improve diabetes treatment and control, ultimately promoting the widespread use of SGLT2 inhibitors.
๐๐จ๐ฉ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ:
With so many businesses involved, the market is projected to become more competitive as it continues to grow.
Here are the top companies in the Europe SGLT2 inhibitors market:
โข AstraZeneca
โข Boehringer Ingelheim International GmbH
โข Bristol-Myers Squibb Company
โข Eli Lilly and Company
โข Glenmark Pharmaceuticals Ltd.
โข Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals, Inc.)
โข Lexicon Pharmaceuticals, Inc.
โข Merck & Co., Inc.
โข Novo Nordisk
โข Sanofi
โข Pfizer Inc.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐ ๐๐ข๐ฌ๐๐จ๐ฎ๐ง๐ญ ๐จ๐ง ๐ญ๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐๐จ๐ซ๐ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐:
https://www.polarismarketresearch.com/industry-analysis/europe-sglt2-inhibitors-market/request-for-discount-pricing
๐๐จ๐ฎ๐ง๐ญ๐ซ๐ฒ-๐๐ข๐ฌ๐ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ:
According to regional analysis, the UK held the largest market share in 2023. The country's National Health Service (NHS) has a robust structure and broad access, making advanced diabetes treatments like SGLT2 inhibitors widely available.
Also, during the projection period, Germany is anticipated to experience substantial growth. The presence of top pharmaceutical companies and continuous research and development efforts have bolstered the availability and use of SGLT2 inhibitors in the country.
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ฅ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค:
๐๐ฒ ๐๐ง๐๐ข๐๐๐ญ๐ข๐จ๐ง ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค
โข Cardiovascular
โข Chronic Kidney Disease (CKD)
โข Type 2 Diabetes
โข Others
๐๐ฒ ๐๐ซ๐ฎ๐ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค
โข Farxiga (Dapagliflozin)
โข Inpefa (Sotagliflozin)
โข Invokana (Canagliflozin)
โข Jardiance (Empagliflozin)
โข Qtern (Dapagliflozin/Saxagliptin)
โข Other SGLT2 Inhibitors
๐๐ฒ ๐๐ข๐ฌ๐ญ๐ซ๐ข๐๐ฎ๐ญ๐ข๐จ๐ง ๐๐ก๐๐ง๐ง๐๐ฅ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค
โข Hospital Pharmacies
โข Online Pharmacies
โข Retail Pharmacies
๐๐ฒ ๐๐จ๐ฎ๐ง๐ญ๐ซ๐ฒ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค
โข Germany
โข France
โข UK
โข Italy
โข Spain
โข Netherlands
โข Russia
โข Rest of Europe
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐๐ก๐ ๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐ ๐๐จ๐ฆ๐ฉ๐ซ๐๐ก๐๐ง๐ฌ๐ข๐ฏ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ซ๐:
https://www.polarismarketresearch.com/industry-analysis/europe-sglt2-inhibitors-market
๐๐ฎ๐ซ๐จ๐ฉ๐ ๐๐๐๐๐ ๐๐ง๐ก๐ข๐๐ข๐ญ๐จ๐ซ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ
โข In terms of drug, the Jardiance (Empagliflozin) segment accounted for the largest revenue share in the Europe SGLT2 inhibitors market in 2023. Major health organizations and regulatory bodies such as the European Medicines Agency (EMA) and the American Diabetes Association (ADA) recommend the use of Jardiance for the treatment of type 2 diabetes.
โข The type 2 diabetes segment, by indication, is expected to register the highest CAGR during the forecast period. Governments and healthcare organizations in Europe are implementing policies and initiatives such as promoting early diagnosis through regular screenings, funding diabetes education programs, and subsidizing the cost of medications. Such measures increase accessibility and affordability of diabetes treatments, boosting market growth.
โข In 2023, the UK accounted for the largest share of the Europe SGLT2 inhibitors market. The country hosts numerous prominent pharmaceutical companies and research institutions committed to advancing and commercializing treatments for diabetes.
โข AstraZeneca; Boehringer Ingelheim International GmbH; Bristol-Myers Squibb Company; Eli Lilly and Company; Glenmark Pharmaceuticals Ltd.; Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals, Inc.); Lexicon Pharmaceuticals, Inc.; Merck & Co., Inc.; Novo Nordisk; Sanofi; and Pfizer Inc. are among the key players in Europe.
๐๐จ๐ซ๐ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ญ๐๐ฌ๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐ฒ ๐๐จ๐ฅ๐๐ซ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
๐๐ฅ๐ข๐ง๐ข๐๐๐ฅ ๐๐ซ๐ข๐๐ฅ ๐๐ฎ๐ญ๐ฌ๐จ๐ฎ๐ซ๐๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ
https://www.polarismarketresearch.com/industry-analysis/clinical-trials-outsourcing-market
๐๐๐๐ข๐๐๐ฅ ๐๐๐ฉ๐๐ฌ ๐๐ง๐ ๐๐๐ง๐๐๐ ๐๐ฌ ๐๐๐ซ๐ค๐๐ญ
https://www.polarismarketresearch.com/industry-analysis/medical-tapes-and-bandages-market
๐๐ข๐๐ซ๐จ๐๐ข๐จ๐ฆ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐ซ๐๐ฉ๐๐ซ๐๐ญ๐ข๐จ๐ง ๐๐๐๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ ๐๐๐ซ๐ค๐๐ญ
https://www.polarismarketresearch.com/industry-analysis/microbiome-sample-preparation-technology-market
๐๐ฌ๐จ๐ญ๐ก๐๐ซ๐ฆ๐๐ฅ ๐๐ฎ๐๐ฅ๐๐ข๐ ๐๐๐ข๐ ๐๐ฆ๐ฉ๐ฅ๐ข๐๐ข๐๐๐ญ๐ข๐จ๐ง ๐๐๐๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ ๐๐๐ซ๐ค๐๐ญ
https://www.polarismarketresearch.com/industry-analysis/isothermal-nucleic-acid-amplification-technology-market
๐๐ซ๐จ๐ญ๐๐ข๐ง ๐๐ฑ๐ฉ๐ซ๐๐ฌ๐ฌ๐ข๐จ๐ง ๐๐๐ซ๐ค๐๐ญ
https://www.polarismarketresearch.com/industry-analysis/protein-expression-market
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Europe SGLT2 Inhibitors Market Opportunity, Challenge, Trend, Global Business Growth Forecast By 2023-2032 | AstraZeneca, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company here
News-ID: 3692786 • Views: โฆ
More Releases from Polaris Market Research & Consulting
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of โฆ
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. Itโฆ
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 โฆ
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 3.82 billion in 2024 and is expected toโฆ
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin โฆ
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billionโฆ
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 โฆ
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 31.67 billion in 2024 and is expected to reachโฆ
More Releases for SGLT2
SGLT2 Inhibitors Market to Accelerate Through 2034 with Expanding Indications an โฆ
Sodium-glucose co-transporter 2 (SGLT2) inhibitors have redefined the treatment paradigm for type 2 diabetes and are rapidly gaining traction across cardio-renal-metabolic diseases. Initially developed for glycemic control, this novel drug class has shown remarkable benefits in reducing cardiovascular and renal risks, propelling it beyond diabetic care into broader chronic disease management.
DelveInsight's latest report, "SGLT2 Inhibitors - Market Size, Target Population, Competitive Landscape & Market Forecast - 2034," offers a deepโฆ
Prominent Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Trend for 202 โฆ
What Are the Projected Growth and Market Size Trends for the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market?
In the past few years, the market size for sodium glucose cotransporter 2 (SGLT2) inhibitors has seen a robust growth. From $10.17 billion in 2024, it is projected to expand to $11.07 billion in 2025, experiencing an 8.8% compound annual growth rate (CAGR). This upward trend during the historical time frame isโฆ
SGLT2 Inhibitors Market to Witness Huge Growth by 2032
The SGLT2 Inhibitors Market 2024 Report makes available the current and future technical and financial analysis of the industry. It is one of the most comprehensive and important additions to the USD Analytics archive of market research studies. It offers detailed research and analysis of key aspects of the global SGLT2 Inhibitors market. This global report explores the key factors affecting the growth of the dynamic SGLT2 Inhibitors market, includingโฆ
SGLT2 Inhibitor Market Analysis and Future Prospects for 2030
The world of the sglt2 inhibitor market is a complex and ever-evolving landscape, shaped by consumer demands and technological advancements. In this report, we delve into the depths of this market to provide a profound and comprehensive analysis, catering to a diverse audience that includes manufacturers, suppliers, distributors, and investors. Our primary goal is to empower industry stakeholders with invaluable insights to make informed decisions in a rapidly changing environment.โฆ
EU SGLT2 Inhibitor Market 2023 Share, Size, Key Players, Revenue Analysis | Prud โฆ
The EU SGLT2 Inhibitor Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global EU SGLT2 Inhibitor market. This report explores all the key factors affecting the growth of the global EU SGLT2โฆ
SGLT2 Inhibitors Treatment Market Current and Future Industry Landscape Analysis โฆ
SGLT2 Inhibitors Treatment market is looking forward to grow at a higher rate in the forecast period of 2021-2031. SGLT2 Inhibitors help in reabsorption of glucose from the kidney leading to low blood glucose level.
SGLT 2 inhibitors is said to grow the market in the near future as the consumption of the antidiabetics drugs is taking a spike. These have high consumption rate as the prevalence of type 2 diabetesโฆ
